Versant Capital Management, Inc Ligand Pharmaceuticals Inc Transaction History

Versant Capital Management, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$69.53 - $79.33 $973 - $1,110	-14 Reduced 66.67%	7 $0
Q3 2022 Dec 30, 2022	BUY	$0.01 - $107.56 $0 - $1,505	14 Added 200.0%	21 $2,000
Q1 2022 Apr 29, 2022	SELL	$94.99 - $151.56 $379 - $606	-4 Reduced 36.36%	7 $1,000
Q4 2021 Jan 06, 2022	SELL	$127.69 - $165.85 $12,002 - $15,589	-94 Reduced 89.52%	11 $2,000
Q3 2021 Oct 29, 2021	BUY	$102.33 - $144.73 $10,744 - $15,196	105 New	105 $15,000
Q1 2020 Apr 17, 2020	SELL	$63.37 - $107.88 $506 - $863	-8 Closed	0 $0
Q3 2019 Oct 18, 2019	BUY	$86.25 - $120.16 $690 - $961	8 New	8 $0

255

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.87B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.